Vijay Watson

DNP Doctor of Nursing Practice,  Mayo Clinic - Rochester 

Location: India

Consulting Services

Biostatistics Hospital-Pharmacy-Insurance Pharma-CRO-Device

Areas Of Interest

Cerebral Ventricle Distempers, Canine Effects, Founder Tick Control Vagal-immune Interaction Cerebroside Sulfatase Deficiency Waste Products ID DNA Binding Protein Inhibitor Control, Narcotic Inbred HRS Mice Peripheral Nervous System Disorders Phosphofructokinase-1, Muscle Type Adenine Immunoglobulin Secreting Cells Cyst, Branchial Cleft Dystrophies, Groenouw's CS514 Visual Illusion WASP Protein SOX10 Transcription Factor Inner Root Sheath Keratins Lissencephalia Motor Neuron Disease, Upper Caulophyllum thalictroide Cytochrome c Peroxidase Protein, Wnt-3 Maximal Midexpiratory Flow Rate Acid Lipase B Police Officers Chick Embryos Fluconazol Stada SSPE Virus

Professional Narrative

Dr. Vijay Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 2014
Assistant Professor, Amgen 2003

Education

Director Medicine, Perelman School of Medicine 2012
Bachelor of science in nursing, Harvard Medical School 2005

Referees


Publications

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :